Reply to Weinberger.

Birring, Surinder S; Morice, Alyn H; Dicpinigaitis, Peter V; McGarvey, Lorcan P; Pavord, Ian D; Green, Stuart A; Philip, George; Smith, Jaclyn A

Birring, Surinder S; Morice, Alyn H; Dicpinigaitis, Peter V; McGarvey, Lorcan P; Pavord, Ian D; Green, Stuart A; Philip, George; Smith, Jaclyn A.

Afiliación

Birring SS; Centre for Human & Applied Physiological Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
Morice AH; Hull York Medical School, Cottingham, United Kingdom.
Dicpinigaitis PV; Albert Einstein College of Medicine & Montefiore Medical Center, Bronx, New York.
McGarvey LP; Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.
Pavord ID; National Institute for Health Research Respiratory Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Green SA; Merck & Co., Inc., Rahway, New Jersey; and.
Philip G; Merck & Co., Inc., Rahway, New Jersey; and.
Smith JA; Division of Immunology, Immunity to Infection & Respiratory Medicine, University of Manchester & Manchester University NHS Trust, Manchester, United Kingdom.

Am J Respir Crit Care Med ; 207(12): 1650-1651, 2023 Jun 15.

Article en En | MEDLINE | ID: mdl-37104844

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google